Blue Trust’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Blue Trust's RXRX Position: Q3 2026 in Review
Blue Trust held its Recursion Pharmaceuticals (RXRX) position steady in Q3 2026 at 324 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2125.
Blue Trust first reported a position in RXRX in Q1 2023 and has held it in 8 quarters since. The position peaked at $9.34K in Q4 2024. 273 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Blue Trust held 324 shares of Recursion Pharmaceuticals worth $1.34K as of Q3 2026.
- Blue Trust left its Recursion Pharmaceuticals share count unchanged in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2125 holding.
- Blue Trust first reported a position in Recursion Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
- Blue Trust's Recursion Pharmaceuticals position peaked at $9.34K in Q4 2024.
- 273 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.